Trailing-twelve-month (TTM) revenue is $2.60 Billion with a year-over-year growth of +19.52%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $621,942,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2026-01-03 | $662,480,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-19 |
| Q1 FY2026Period ended 2026-04-04 | $647,915,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-07-04 | $670,483,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $2,602,820,000 |
Current P/S: $2,692,543,085 market capitalization ÷ $2,602,820,000 TTM revenue = 1.03x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:25:30.000Z. Latest revenue period ended 2026-07-04.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-07-04): $670.48M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:26:02.083Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212022-01-01 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252026-01-03 · USD |
|---|---|---|---|---|---|
| Home Health And Hospice | $177M | $233M | $219M | $218M | $249M |
| Medical Solutions | $143M | $140M | $158M | $172M | $183M |
| Private Duty Services |
$2.60B
$2.60 Billion
+19.52%
vs. $2.18B a year ago (TTM)
+9.65%
5 Year compound annual growth rate
1 Year
+19.52%
3 Year
+12.37%
5 Year
+9.65%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.43B | +$408.69M | +20.19% |
| 2024 | $2.02B | +$129.30M | +6.82% |
| 2023 | $1.90B | +$107.56M | +6.02% |
| 2022 | $1.79B | +$109.03M | +6.50% |
| 2021 | $1.68B | +$183.51M | +12.27% |
| 2020 |
TTM Growth
+19.52%
3-Year CAGR
+12.37%
5-Year CAGR
+9.65%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:26:02.083Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $1.4B |
| $1.4B |
| $1.5B |
| $1.6B |
| $2.0B |
| $1.50B |
| +$111.04M |
| +8.02% |
| 2019 | $1.38B | +$130.39M | +10.40% |
